Kunio Motohashi
Overview
Explore the profile of Kunio Motohashi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
16
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nozawa T, Okamoto K, Nakazato S, Motohashi K, Suzuki T, Morita K, et al.
J Neurosurg Case Lessons
. 2022 Jul;
1(8):CASE2061.
PMID: 35855310
Background: Bow hunter's syndrome or stroke (BHS) is characterized by rotational vertebrobasilar insufficiency elicited by rotation of the neck. It is caused by dynamic and reversible occlusion of the vertebral...
2.
Natsumeda M, Igarashi H, Gabdulkhaev R, Takahashi H, Motohashi K, Ogura R, et al.
Diagnostics (Basel)
. 2021 Nov;
11(11).
PMID: 34829476
We have previously published a study on the reliable detection of 2-hydroxyglutarate (2HG) in lower-grade gliomas by magnetic resonance spectroscopy (MRS). In this short article, we re-evaluated five glioma cases...
3.
Saito S, Hasegawa H, Sato D, Ando K, Motohashi K, Natsumeda M, et al.
No Shinkei Geka
. 2020 Jun;
48(6):527-532.
PMID: 32572005
Although blunt carotid artery injury is known as an important cause of ischemic stroke, the role of the endovascular treatment for acute ischemic stroke related to blunt carotid injuries remains...
4.
Natsumeda M, Motohashi K, Igarashi H, Nozawa T, Abe H, Tsukamoto Y, et al.
Neurosurg Rev
. 2017 Sep;
41(2):641-647.
PMID: 28956184
We have previously reported that reliable detection of 2-hydroxyglutarate (2HG) in isocitrate dehydrogenase (IDH)-mutant WHO grade 2 and 3 gliomas is possible utilizing 3.0-T single-voxel magnetic resonance spectroscopy (SVMRS). We...
5.
Okamoto K, Motohashi K, Fujiwara H, Ishihara T, Ninomiya I, Onodera O, et al.
Brain Nerve
. 2017 Feb;
69(2):129-141.
PMID: 28202821
Posterior reversible encephalopathy syndrome (PRES) is suggested in patients with acute neurological symptoms in the appropriate clinical context, including acute hypertension, blood pressure fluctuations, renal failure, blood transfusion, immunosuppression, autoimmune...